Author:
Moore M.,Gill S.,Asmis T.,Berry S.,Burkes R.,Zbuk K.,Alcindor T.,Jeyakumar A.,Chan T.,Rao S.,Spratlin J.,Tang P.A.,Rothenstein J.,Chan E.,Bendell J.,Kudrik F.,Kauh J.,Tang S.,Gao L.,Kambhampati S.R.P.,Nasroulah F.,Yang L.,Ramdas N.,Binder P.,Strevel E.
Reference12 articles.
1. [IARC] International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 (colorectum fact sheet, published 2015). http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (24 June 2015, date last accessed).
2. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Van Cutsem;Ann Oncol,2014
3. VEGF targets the tumour cell;Goel;Nat Rev Cancer,2013
4. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial;Kabbinavar;J Clin Oncol,2005
5. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献